Potassium Ion

Potassium Ion

SCHEMBL16653556

[BH4-].[K+].[Na+].[SH-]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

AGTR1DHFRGABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTNR3C2PBP2XPTGS1PTGS2VKORC1blablaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAftsImrcAmrcBmrdApbp1apbp1bpbp2apbp2bpbp3polthyA

The experimentally established mechanism targets of Potassium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Potassium Ion SCHEMBL5056227 0.87 — —
Potassium Ion SCHEMBL8888211 0.87 — —
Potassium Ion SCHEMBL11612795 0.75 — —
Potassium Ion SCHEMBL5228448 0.75 — —
SCHEMBL80 0.71 — —
Potassium Ion SCHEMBL63086 0.71 — —
SCHEMBL5398067 0.71 — —
SCHEMBL5247960 0.71 — —
Potassium Ion SCHEMBL9450128 0.71 — —
Hydrogen Sulfide SCHEMBL6248 0.71 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240166605-A1 PROCESS FOR THE PREPARATION OF A PDE4 INHIBITOR CHIESI FARMACEUTICI S.P.A. (IT) 2024-05-23 — — US disclosed
US-11981639-B2 Process for the preparation of a PDE4 inhibitor CHIESI FARMACEUTICI S.P.A. (IT) 2024-05-14 — — US disclosed
EP-3587400-B1 PROCESS FOR THE PREPARATION OF A PDE4 INHIBITOR CHIESI FARM SPA (IT) 2024-03-20 — — EP disclosed
US-20220348545-A1 PROCESS FOR THE PREPARATION OF A PDE4 INHIBITOR CHIESI FARMACEUTICI S.P.A. (IT) 2022-11-03 — — US disclosed
EP-4059921-A1 PROCESS FOR THE PREPARATION OF A PDE4 INHIBITOR Chiesi Farmaceutici S.p.A. (IT) 2022-09-21 — — EP disclosed
US-11352327-B2 Process for the preparation of a PDE4 inhibitor CHIESI FARMACEUTICI S.P.A. (IT) 2022-06-07 — — US disclosed
EP-3798209-A1 PROCESS FOR THE PREPARATION OF A CRYSTAL FORM OF A PDE4 INHIBITOR Chiesi Farmaceutici S.p.A. (IT) 2021-03-31 — — EP disclosed
US-20210040040-A1 PROCESS FOR THE PREPARATION OF A PDE4 INHIBITOR CHIESI FARMACEUTICI S.P.A. (IT) 2021-02-11 — — US disclosed
EP-3293176-B1 CRYSTAL FORM OF A PDE4 INHIBITOR CHIESI FARM SPA (IT) 2020-12-02 — — EP disclosed
US-10759761-B2 Process for the preparation of a PDE4 inhibitor CHIESI FARMACEUTICI S.P.A. (IT) 2020-09-01 — — US disclosed
EP-3060551-B1 PROCESS FOR THE PREPARATION OF A PDE4 INHIBITOR CHIESI FARM SPA (IT) 2019-09-18 — — EP disclosed
US-10323003-B2 Process for the preparation of a PDE4 inhibitor CHIESI FARMACEUTICI S.P.A. (IT) 2019-06-18 — — US disclosed
US-20180118686-A1 PROCESS FOR THE PREPARATION OF A PDE4 INHIBITOR CHIESI FARMACEUTICI S.P.A. (IT) 2018-05-03 — — US disclosed
EP-3293176-A1 CRYSTAL FORM OF A PDE4 INHIBITOR Chiesi Farmaceutici S.p.a. (IT) 2018-03-14 — — EP disclosed
US-9890122-B2 Process for the preparation of a PDE4 inhibitor CHIESI FARMACEUTICI S.P.A. (IT) 2018-02-13 — — US disclosed
US-20160326117-A1 PROCESS FOR THE PREPARATION OF A PDE4 INHIBITOR CHIESI FARMACEUTICI S.P.A. (IT) 2016-11-10 — — US disclosed
US-9434691-B2 Process for the preparation of a PDE4 inhibitor CHIESI FARMACEUTICI S.P.A. (IT) 2016-09-06 — — US disclosed
EP-3060551-A1 PROCESS FOR THE PREPARATION OF A PDE4 INHIBITOR Chiesi Farmaceutici S.p.A. (IT) 2016-08-31 — — EP disclosed
WO-2015059050-A1 PROCESS FOR THE PREPARATION OF A PDE4 INHIBITOR CHIESI FARMACEUTICI S.P.A. (IT) 2015-04-30 — — WO disclosed
US-20150111931-A1 PROCESS FOR THE PREPARATION OF A PDE4 INHIBITOR CHIESI FARMACEUTICI S.P.A. (IT) 2015-04-23 — — US disclosed
Send feedback